Evaxion Biotech Q1 EPS $(0.01) Beats $(0.23) Estimate

Benzinga Newsdesk www.benzinga.com Negative 95.1%

Neg 95.1% Neu 0% Pos 0%

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.23) by 95.65 percent. This is unchanged from the same period last year.